BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?

Surein Arulananda¹, Paul Mitchell²

Affiliations

¹ Cancer Immuno-Biology Laboratory, Olivia-Newton John Cancer Research Institute, Heidelberg, Australia; School of Cancer Medicine, La Trobe University, Heidelberg, Australia; Department of Medical Oncology, Austin Health, Heidelberg, Australia.
² Cancer Immuno-Biology Laboratory, Olivia-Newton John Cancer Research Institute, Heidelberg, Australia; Department of Medical Oncology, Austin Health, Heidelberg, Australia; Department of Medicine, University of Melbourne, Parkville, Australia. Electronic address: Paul.MITCHELL@austin.org.au.

PMID: 30056857
DOI: 10.1016/j.jtho.2018.06.002

Free article

Editorial

BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?

Surein Arulananda et al. J Thorac Oncol. 2018 Aug.

Free article

. 2018 Aug;13(8):1055-1057.

doi: 10.1016/j.jtho.2018.06.002. Epub 2018 Jul 2.

Authors

Surein Arulananda¹, Paul Mitchell²

Affiliations

¹ Cancer Immuno-Biology Laboratory, Olivia-Newton John Cancer Research Institute, Heidelberg, Australia; School of Cancer Medicine, La Trobe University, Heidelberg, Australia; Department of Medical Oncology, Austin Health, Heidelberg, Australia.
² Cancer Immuno-Biology Laboratory, Olivia-Newton John Cancer Research Institute, Heidelberg, Australia; Department of Medical Oncology, Austin Health, Heidelberg, Australia; Department of Medicine, University of Melbourne, Parkville, Australia. Electronic address: Paul.MITCHELL@austin.org.au.

PMID: 30056857
DOI: 10.1016/j.jtho.2018.06.002

No abstract available

PubMed Disclaimer

Comment on

BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors.
Dudnik E, Peled N, Nechushtan H, Wollner M, Onn A, Agbarya A, Moskovitz M, Keren S, Popovits-Hadari N, Urban D, Mishaeli M, Zer A, Allen AM, Rabinovich NM, Rotem O, Kuznetsov T, Shochat T, Roisman LC, Bar J; Israel Lung Cancer Group. Dudnik E, et al. J Thorac Oncol. 2018 Aug;13(8):1128-1137. doi: 10.1016/j.jtho.2018.04.024. Epub 2018 Apr 30. J Thorac Oncol. 2018. PMID: 29723688

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?

Affiliations

BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?

Authors

Affiliations

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials